AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
A Legacy of Biodiversity and Biomedical Excellence
Founded in 1984 by Mary-Ann and Owen Griffiths, Bioculture’s story began with a bold vision: to turn the ecological threat posed by the introduced Mauritian cynomolgus macaques into an invaluable resource for biomedical research. Today, these primates, renowned for their 100% specific pathogen-free status, play a critical role in the preclinical trial phases of drug and treatment development.
Bioculture’s operations are grounded in its commitment to ethical and sustainable practices. The company’s founders remain dedicated to preserving the endemic and endogenous biodiversity of the Indian Ocean region, reinvesting a significant portion of profits into conservation initiatives across Mauritius and Madagascar. This harmonious balance of commercial success and environmental stewardship reflects Bioculture’s ethos of “Caring for Life.”
Franklin Biolabs: Accelerating Medical Breakthroughs
In October 2024, Bioculture took a transformative step by acquiring a majority stake in Franklin Biolabs through its investment vehicle, Savanne Life Sciences. This strategic move signifies Bioculture’s evolution within the biomedical research value chain, enabling the company to play a more direct role in advancing genetic medicine research and innovation.
With a vision to be the leading, trusted provider of comprehensive solutions for the global Genetic Medicines industry, Franklin Biolabs, is at the forefront of developing next-generation treatments.
A Vision for the Future
As Bioculture continues to advance its mission of “Caring for Life,” it remains guided by its core values of animal welfare, environmental sustainability, and personnel well-being to create a healthier, more sustainable world. By embracing innovation and responsibility, Bioculture and its partners, like Franklin Biolabs, are setting new benchmarks in the global health ecosystem.
Watch the Campaign live on Reuters.
For media inquiries, please contact:
Anupah Makoond
Group Head of Policy and Communications
[email protected]
Eloise McKenna
Acumen Media
+44 20 3553 3664
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
